Cardinal Health Inc
CAH: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$969.00 | Zrxtnzq | Wfprvmxmx |
Cardinal Health Shows Resilience Amid Cost Inflation; Slightly Raising Fair Value Estimate
Narrow-moat Cardinal Health posted strong fiscal fourth-quarter results despite heightened supply chain constraints, rounding out a solid fiscal year. Following an announced leadership transition, the firm maintained its positive 2023 guidance. Given Cardinal's resilience against this quarter’s heavy cost pressures, we plan to slightly raise our fair value estimate.